Home/Filings/4/0001562180-17-001137
4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001562180-17-001137

CIK 0000835887operating

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 11:36 AM ET

Size

5.3 KB

Accession

0001562180-17-001137

Insider Transaction Report

Form 4
Period: 2017-03-01
Tenbarge Bryce
Vice President, Commercial
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2017-03-01+66,00066,000 total
    Exercise: $11.32Exp: 2027-03-01Common Stock (66,000 underlying)
Footnotes (1)
  • [F1]3yr 33% On Vest beginning on 01-Mar-2017

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000835887

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 11:36 AM ET
Size
5.3 KB